S100A11 and ovarian benign neoplasm: In this study, enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of serum S100A11 and MMP9 in patients with EOC, patients with benign ovarian tumor, and healthy women to explore the correlation between the two potential markers and their relationship with EOC invasion and metastasis.